Home › Diffuse Intrinsic Pontine Glioma › Alabama
Diffuse Intrinsic Pontine Glioma clinical trials in Alabama
3 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in Alabama.
Cities in Alabama
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's Hospital of Alabama, Birmingham
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Alabama/Children's of Alabama, Birmingham
RecruitingPhase 1/2
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199Combination Therapy for the Treatment of Diffuse Midline Gliomas
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 2
Ages 2 to 39 · All sexes · Updated Jun 26, 2026 · NCT05009992From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.